Quick Takeaways
- TomEnterprise AB filed SCHEDULE 13G/A for DiaMedica Therapeutics Inc. Common Shares, no par value (DMAC).
- Disclosed ownership: 16%.
- Date of event: 23 Jul 2025.
TomEnterprise AB - 23 Jul 2025 SCHEDULE 13G/A Report for DiaMedica Therapeutics Inc. Common Shares, no par value (DMAC)
- Filing Manager
- TomEnterprise AB
- Reporting Manager
- TomEnterprise AB
- Symbol
- DMAC
- Shares outstanding
- 51,496,173 shares
- Disclosed Ownership
- 8,383,577 shares
- Ownership
- 16%
- Form type
- SCHEDULE 13G/A
- Filing time
- 30 Jul 2025, 17:31:32 UTC
- Date of event
- 23 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"TomEnterprise AB disclosed 16% ownership in DiaMedica Therapeutics Inc. Common Shares, no par value (DMAC) on 23 Jul 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 30 Jul 2025, 17:31.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TomEnterprise AB | 16% | 8,383,577 | 0 | 8,383,577 | /s/ Per Colleen | Chief Executive Officer | |
| TomEnterprise Private AB | 16% | 8,383,577 | 0 | 8,383,577 | /s/ Per Colleen | Chief Executive Officer | |
| Thomas von Koch | 16% | 8,383,577 | 0 | 8,383,577 | /s/ Thomas von Koch | Thomas von Koch |